Navigation Links
Scientists puzzled by severe allergic reaction to cancer drug in the middle Southern US
Date:8/20/2007

CHAPEL HILL A patients expectations about the side effects of chemotherapy usually focus on nausea, hair loss, fatigue and other side effects. Worries about severe allergic reactions to their therapy is usually not a concern.

A recent study from the Lineberger Comprehensive Cancer Center at the University of North Carolina at Chapel Hill, the Vanderbilt-Ingram Comprehensive Cancer Center and the Sarah Canon Cancer Center in Nashville have identified an unusually high rate of allergic reaction in cancer patients living in the middle South who received a common drug used for treating their cancer.

This study was presented at the 43rd annual meeting of the American Society of Clinical Oncology in Chicago in June, 2007 and appears online Aug. 17th in the Journal of Clinical Oncology.

The drug, cetuximab, marketed by Bristol-Meyers Squibb as Erbitux, is a widely used chemotherapeutic agent for treating colon cancer, head and neck tumors, and is being studied in the treatment of ovarian, lung, breast and gastrointestinal tumors.

When cetuximab was first approved, the first three patients treated at UNC had severe reactions to the drug. Doctors at both Sarah Canon and Vanderbilt also had more patients than expected react with a drop in blood pressure and shortness of breath or other hypersensitivity reactions within minutes of infusion of cetuximab.

After speaking with others, we realized that patients who lived on a line across North Carolina, Tennessee, northern Arkansas and southern Missouri had these adverse reactions to the drug, said study leader Dr. Bert ONeil, assistant professor of medicine, division of hematology and oncology at UNC. So, we thought it appropriate to see what common bonds were there.

Cancer researchers from UNC and Vanderbilt pooled their patients dating back to when the drug received approval from the Food and Drug Administration, in 2004. More than 140 patients from ongoing clinical trials (at Vanderbilt) and current clinical records (at UNC) were reviewed for the presence of immediate, severe hypersensitivity reactions as well as pertinent demographics to determine this regions rate of allergic reactions and to see if a profile of the potentially allergic patient was evident.

The nationwide rate of severe allergic reactions to cetuximab is only about 2 percent. However, 22 percent of patients in this study showed severe allergic reactions to the drug. Cetuximab normally is infused over a two-hour period, but allergic patients had a reaction within minutes of starting the infusion, a classic anaphylactic reaction. The strongest predictor of a reaction to cetuximab was a history of other hypersensitivities, such as allergic asthma, food allergies, bee stings or allergies to other drugs, such as penicillin.

What is it about this strip across the middle South" A good question, said ONeil. The most likely places to look would be food- or plant-based allergens. If it is of plant origin, finding the source could be a needle-in-a-haystack search. And its a narrow geographic band; colleagues in Atlanta or the University of Virginia havent seen this type of reaction.

The research team felt that clinicians in this middle South region must obtain a thorough history of allergic reaction and be prepared to use an alternative drug, such as panitumimab, for patients with a history of hypersensitivity reactions, ONeil said.

Bristol-Myers Squibb is studying a screening test for the specific factor that leads to the reaction. In the meantime, doctors in the middle South need to be aware of, and be prepared to treat, sudden, severe allergic reactions when using cetuximab, ONeil said.

Based on the results of this study, UNC has a physician, physician assistant or nurse practitioner present for the first 30 minutes of all infusions of cetuximab. The Sarah Cannon Cancer Center halted all studies the drug.

This is a curious problem, but not a problem we cant deal with, said ONeil. As long as we know the patients allergy history, we know what to do.


'/>"/>

Contact: Les Lang
llang@med.unc.edu
919-843-9687
University of North Carolina at Chapel Hill
Source:Eurekalert

Related medicine news :

1. Nobel Prize for Medicine shared by Three scientists
2. Scientists plan human cloning clinic in the United States
3. Scientists crack dengue fever puzzle
4. Scientists found ancient Human Germ Killer
5. Scientists locate key hormone involved in appetite control
6. Scientists open the book of life
7. Electronic nose by Italian scientists
8. Scientists review SARS
9. Scientists push to lower hidden sodium in food
10. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
11. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/16/2018)... (PRWEB) , ... October 16, 2018 , ... ... was the recipient of the Academy of Integrative Health and Medicine’s (AIHM) Visionary ... to natural medicine. , Dr. Pizzorno was selected as AIHM’s recipient of ...
(Date:10/16/2018)... ... 2018 , ... dicentra Global Certifications, an affiliate of dicentra Cannabis Consulting, has ... become the first G7 country in the world to formally legalize the recreational production ... legalize the production and use of cannabis edibles. , More than one in four ...
(Date:10/16/2018)... ... 16, 2018 , ... Sheba Vine, JD, CPCO, Vice President ... writes frequently on employment law matters and has contributed articles to Compliance Today, ... Care Compliance Professional's Manual titled “Navigating the Evolving Marijuana Landscape” to serve as ...
(Date:10/16/2018)... ... ... are over. The race has come and gone. It doesn’t matter if runners come in ... after the big event. Read on for something healthy hints from the Austin family ... body and mind after a long run: , 1. Don’t sit. Walk around for a ...
(Date:10/16/2018)... ... October 16, 2018 , ... BlueCloud ... by patient-survivors, and The Avoca Group, Inc., a life sciences consulting firm ... today announced its mutual collaboration that will make Avoca’s industry research results, ...
Breaking Medicine News(10 mins):
(Date:10/20/2018)... ... , ... Dr. Rajdeep S. Randhawa of Innovative Dentistry has been reviewed ... and Restorative Dentistry’ which includes an exclusive group of 6 Top Dentists out ... dentist website. Dr. Randhawa has been practicing dentistry since 1988 and specializes in ...
(Date:10/18/2018)... CLEARWATER, Fla. (PRWEB) , ... October 18, 2018 ... ... platform dedicated to simplifying the process of buying insurance, announced today the launch ... EZ-App was developed by Ensurem as part of its mission to streamline the ...
(Date:10/17/2018)... ... 17, 2018 , ... Dr. Dan Holtzclaw, Chief Clinical Officer ... use of placental based growth factors for the treatment of nerve injuries related ... DIA Dental Implant Center locations in Austin and San Antonio, we occasionally see ...
Breaking Medicine Technology: